摘要
目的:探讨为急性发作期支气管哮喘(简称为哮喘)患儿使用布地奈德进行氧驱动雾化吸入治疗的效果.方法:将2016年1月至2017年12月期间井研县妇幼保健院收治的84例急性发作期哮喘患儿作为研究对象.将这84例患儿随机分为观察组和对照组,每组各有42例患儿.为两组患儿均进行常规治疗,在此基础上,为观察组患儿使用布地奈德进行氧驱动雾化吸入治疗.然后,对比两组患儿的治疗效果及治疗过程中其不良反应的发生情况.结果:与对照组患儿相比,观察组患儿治疗的总有效率较高,其在治疗过程中不良反应的发生率较低,P<0.05.结论:为急性发作期哮喘患儿使用布地奈德进行氧驱动雾化吸入治疗的效果显著,且安全性较高.
objective: to investigate the efficacy of budesonide in the treatment of acute bronchial asthma (asthma). Methods: from January 2016 to December 2017, 84 children with acute attack asthma admitted to jingyan county maternal and child health care hospital were studied as subjects. The 84 children were randomly divided into observation group and control group, with 42 children in each group. Routine treatment was performed for both groups of children. On this basis, budesonide was used for oxygen-driven atomization inhalation treatment for children in the observation group. Then, the therapeutic effects and adverse reactions of the two groups of children were compared. Results: compared with the control group, the observation group had a higher total effective rate and a lower incidence of adverse reactions during the treatment (P < 0.05). Conclusion: budesonide is effective and safe for children with acute asthma.
作者
李吉平
Li ji ping(department of paediatrics,jingyan county maternal and child health center,sichuan province,jingyan 613100)
关键词
小儿哮喘
急性发作期
布地奈德
氧驱动雾化吸入治疗
pediatric asthma
Acute episode
Boudesnard
Oxygen driven atomization inhalation therapy